Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Dexamethasone vs Etoricoxib in Third Molar Surgery
NCT05142098Phase 1Unknown
- Sponsor
- Dow University of Health Sciences
- Start
- Jan 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of etoricoxib in postoperative pain and trismus (2 arms), sponsored by Dow University of Health Sciences. Primary endpoint: Assessment of post operative complications at 1 week. Status: unknown.
02
Drugs
etoricoxib
03
Conditions
postoperative paintrismus
Beyond the preview
Go deeper on NCT05142098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05142098.